SummaryReactive oxygen species (ROS) in rostral ventrolateral medulla (RVLM) of brainstem contribute to sympathoexcitation and are critically involved in the pathogenesis of hypertension. Baroreflex sensitivity (BRS) is a valuable prognostic parameter of the autonomic nervous system, and is impaired in hypertension. The aim of the present study was to determine whether or not a chronic reduction of ROS in the RVLM improves impaired BRS in hypertensive rats. We transfected adenovirus vectors encoding either manganese superoxide dismutase (AdMnSOD) or β-galactosidase (AdLacZ) into the RVLM of stroke-prone spontaneously hypertensive rats (SHRSP). We measured BRS using the spontaneous sequence method. BRS was significantly lower in SHRSPs than in Wistar-Kyoto rats. In the AdMnSOD-transfected SHRSP, blood pressure, heart rate, and sympathetic nervous system activation were significantly decreased from day 5 after the gene transfer. BRS in the AdMnSOD-transfected SHRSP was significantly increased from day 4 after the gene transfer with the reduction of ROS in the RVLM. Furthermore, in the AdMnSOD-transfected SHRSP, intravenous infusion of atropine dramatically decreased BRS. In contrast, in the AdLacZ-transfected SHRSP, atropine did not decrease BRS. These results suggest that chronic reduction of ROS in the local RVLM improves the impaired BRS in SHRSP through inhibition of the sympathetic component. (Int Heart J 2012; 53: 193-198) Key words: Baroreflex sensitivity, Reactive oxygen species, Brain, Sympathetic nervous system, Hypertension A change in arterial blood pressure (BP), such as that resulting from postural change, is detected by baroreceptors, and the afferent nerves provide the information to the central nervous system. 1,2) The arterial baroreflex regulated by the central nervous system acts to oppose the increase in BP by inhibiting sympathetic activity, causing vasodilation and slowing heart rate (HR) in the short-term.
1,2)Previous reports have suggested that baroreflex sensitivity (BRS) is impaired in cardiovascular diseases such as hypertension, [3][4][5][6] heart failure, 7,8) and myocardial infarction. 9) It has been suggested that BP variability, which is a cardiovascular risk factor, contributes to end-organ damage. [10][11][12] The assessment of BRS has been considered to be the established tool for the evaluation of autonomic control of the cardiovascular system.9,13) Classically, BRS has been evaluated by the drug-induced Oxford method.14) However, pharmacological assessment of BRS is difficult to determine repeatedly in humans, but can be done in acute experiments with anesthetized animals. Recently, the spontaneous sequence method has proved to be a reliable and noninvasive method for assessing BRS, and the assessment of BRS can now be performed repeatedly in humans and animals in a conscious state. 4,15) The rostral ventrolateral medulla (RVLM) is the vasomotor center that determines basal sympathetic nervous system (SNS) activation, and is responsible for maintaining sympathetic out flow...